300 likes | 557 Views
Participants of research . Ministry of Health of Republic Tatarstan Territorial body Roszdravnadzora on Republic Tatarstan of Republic Tatarstan FOMS Laboratory of pharmacoeconomicsIndependent experts Pharmaceutical company "Laboratory Servie" . The purpose of this research . Estimation of use and the subsequent definition of the need for medical products when providing additional free-of-charge medical aid to separate categories of citizens who are having the right of reception9447
E N D
1. Pharmacoepidemiological research: Estimation of use of the medical products which are released under recipes of the doctor (medical assistant) when providing additional free-of-charge medical aid (DLO) to separate categories of citizens who are having the right of reception of the state social help at a regional level
Kulikov A.J. senior scientific employee at a lab of farmacoeconomics of MMA named after Sechenov
Safiullin R.S. professor, managing faculty of management and economy of pharmacy
Yarkaeva F.F. The State Medical University of Kazan
3. The purpose of this research
Estimation of use and the subsequent definition of the need for medical products
when providing additional free-of-charge medical aid to separate categories of citizens who are having the right of reception of the state social help in Republic Tatarstan
4. The tasks that are being worked To estimate volumes and structure of consumption of medical products (MP), received by separate categories of citizens under reembersment system (RS) in 2005
To allocate nosologic forms having the greatest prevalence and/or the greatest financial load
The expert estimation of use of medical products under standards of rational application of MP by the people with diabetes, coronary heart disease (CHD) , hypertonic illness and breast cancer .
5. Further development of research To estimate expenses for medicinal maintenance under program RS, under condition of rational prescription of medicine
To construct the forecast of MP consumption in RS program on 2008
6. Additional tasks To study dynamics of volumes and structures of consumption MP in 2004-2005 by the citizens who received MP under RS program in 2005
To study the possibility of use of data from personified registers of written out and paid medical services and medicines as indicators of conformity of medicinal therapy received by citizens to existing standards of rational therapy
7. The results RS received on all data file for 2005 in Republic Tatarstan
8. Scale of RS program 2005 in Republic Tatarstan Total of participants RS
216722 patients
Total sum of the paid recipes
896 520 300 roubles
Total of the paid recipes
2 543 599 pieces
9. The dynamics of growth of expenses for a year (million rbl.)
10. The dynamics of amount of the paid recipes (thousand)
11. The dynamics of the cost of recipes
12. Average recipe cost Average cost of the recipe has made 355, 59 rbl.
13. Quantity of recipes by age groups
14. Distribution of expenses on age groups (in rbl.)
15. Average of
recipes one
patient
receives
in a month 0,98
16. Average cost for 1 patient a year
17. Preliminary results RS program received during profound research for 2005 in Republic Tatarstan
18. Selection of diseases for the profound research for this purpose data given by FOMC RT have been analysed
19. Pharmacoepidemiological research Definition of sample of patients
Gathering of the information from out-patient cards of patients for 2004-2005
Generalization and statistical data processing of questionnaires
The analysis of MP’s consumption dynamics MP and medical services according to the profound research for 2004-2005
20. Distribution of expenses to medicinal maintenance under RS program in Republic Tatarstan
21. Nosologic groups’s distribution of number of the recipes which have been written out under RS program in Republic Tatarstan
23. Chosen nosologics for study by means of the basic questionnaire The arterial hypertensia
Coronary heart disease, CHD
Diabetes
Breast cancer
24. Main questions in the poll-questionnaire Sex
Age
The basic diagnosis
The accompanying diagnosis
Aftereffects of illness
25. Main questions in the poll-questionnaire,therapy Regular therapy:
prescription of MP in 2004
prescription of MP in 2005
the reason of change of therapy if it was observed
Other therapy:
in any other occasions (influenza , an otitis, etc.) prescription of MP in 2005
26. The analysis of information databases in RS and cards The analysis of structure and completeness of filling of databases
Definition of prevalence of diseases among preferential categories of citizens RT (both chronic, and acute)
Compatibility diseases’s definition
Definition of a share of the citizens, really using preferential medicinal maintenance
Definition of frequencies of MP’s prescription, original, generical medicinal forms
Definition of frequency of MP’s prescription in relation to the most widespread nosologic units
27. Algorithm of work with cards Gathering of the information, entering of data
Formation of an electronic database
Formation of a pool of regional and federal experts
Carrying out of the preliminary analysis
Writing of the conclusion regional experts
Preparation of preliminary results of research
Report on research and the publication of results
28. Preliminary results The statistical analysis of prescription of medicinal therapy now proceeds
During the analysis of a part of questionnaires on cardiovascular therapy within the limits of RS program in RT, preliminary results are received
29. Using inhibitor APF
30. Using a, ß-adrenoblocker
31. Using calcium channel’s blockers
32. Using diuretics
33. The coordinated criteria of antihypertention therapy’s efficiency On a degree of the control the blood pressure:
Therapy is inefficient - target levels of blood pressure are not achieved or achieved, but an achievement is kept no longer than two months in a row.
Therapy is partially effective - target levels of blood pressure are achieved, but kept no more than 3 months.
Therapy is effective - target levels are achieved and kept during all time of supervision, probably incidental (no more than 2 times a year and not successively) excess of target levels of blood pressure.
As a whole 140/90 (blood pressure), for patients with a diabetes, diseases of kidneys - 130/80 (blood pressure).
34. Effectiveness of arterial hypertensia therapy
35. Outpatient reduction of hypertensic crisis
36. Outpatient visits
37. Number of hospitalizations
38. Estimation of rationality of MP’s use The analysis of conformity of therapy to existing standards
Further steps:
Definition of need and volume of expenses on MP
Construction of the forecast of MP’s consumption on 2008
Development of the plan on monitoring and the further optimization of medicinal maintenance in RS system
39. 73 subgroups of patients Criteria: the Arterial hypertensia, CHD, chronic insufficiency of blood circulation, a heart attack of a myocardium in the anamnesis, a diabetes (I or II type), presence of complications of a diabetes, acute stroke of cerebral circulation (on ischemic, to the mixed type, passing), type arrhythmia, presence of accompanying diseases
40. Federal experts Will define the rational scheme of introduction of patients for each of 73 subgroups
Considering frequency of prevalence of each group the forecast of MP’s consumption will be constructed in RS - 2008 in Republic Tatarstan